cediranib (RECENTIN TM, AZD2171)

DRUG2 trials

Sponsors

AstraZeneca

Conditions

Advanced Solid MalignanciesAdvanced Solid Tumors

Phase 1

Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours

CompletedNCT00750425

AstraZenecaAdvanced Solid Tumors

Start: 2008-08-31End: 2011-01-31Target: 46Updated: 2011-03-10

A Study to Determine the Pharmacokinetics of Cediranib in Chinese Patients With Advanced Solid Malignancies

CompletedNCT00981721

AstraZenecaAdvanced Solid Malignancies

Start: 2009-09-30End: 2011-04-30Updated: 2011-06-20